Ranjani Manjunath

Summary

Affiliation: GlaxoSmithKline Research and Development
Country: USA

Publications

  1. doi request reprint Burden of uncontrolled epilepsy in patients requiring an emergency room visit or hospitalization
    Ranjani Manjunath
    GlaxoSmithKline, Research Triangle Park, NC, USA
    Neurology 79:1908-16. 2012
  2. doi request reprint Patients' preferences for treatment outcomes of add-on antiepileptic drugs: a conjoint analysis
    Ranjani Manjunath
    GlaxoSmithKline, Research Triangle Park, NC 27709, USA
    Epilepsy Behav 24:474-9. 2012
  3. doi request reprint Association of antiepileptic drug nonadherence with risk of seizures in adults with epilepsy
    Ranjani Manjunath
    US Health Outcomes, Neurosciences, GlaxoSmithKline, Research Triangle Park, NC 27709, USA
    Epilepsy Behav 14:372-8. 2009
  4. doi request reprint The association between antiepileptic drug and HMG-CoA reductase inhibitor co-medication and cholesterol management in patients with epilepsy
    Sean D Candrilli
    RTI Health Solutions, Research Triangle Park, NC, United States
    Epilepsy Res 91:260-6. 2010

Collaborators

Detail Information

Publications4

  1. doi request reprint Burden of uncontrolled epilepsy in patients requiring an emergency room visit or hospitalization
    Ranjani Manjunath
    GlaxoSmithKline, Research Triangle Park, NC, USA
    Neurology 79:1908-16. 2012
    ..To quantify the clinical and economic burden of uncontrolled epilepsy in patients requiring emergency department (ED) visit or hospitalization...
  2. doi request reprint Patients' preferences for treatment outcomes of add-on antiepileptic drugs: a conjoint analysis
    Ranjani Manjunath
    GlaxoSmithKline, Research Triangle Park, NC 27709, USA
    Epilepsy Behav 24:474-9. 2012
    ..This study aids in better understanding of patients' AED treatment preferences and may aid in management of epilepsy...
  3. doi request reprint Association of antiepileptic drug nonadherence with risk of seizures in adults with epilepsy
    Ranjani Manjunath
    US Health Outcomes, Neurosciences, GlaxoSmithKline, Research Triangle Park, NC 27709, USA
    Epilepsy Behav 14:372-8. 2009
    ..Mean follow-up was 133 days among subjects with event and 305 days for patients without event. Seizure risk was 21% higher among nonadherers (hazard ratio=1.205, P=0.0002) than adherers...
  4. doi request reprint The association between antiepileptic drug and HMG-CoA reductase inhibitor co-medication and cholesterol management in patients with epilepsy
    Sean D Candrilli
    RTI Health Solutions, Research Triangle Park, NC, United States
    Epilepsy Res 91:260-6. 2010
    ..The purpose of this study was to evaluate the association of EIAEDs and non-enzyme-inducing antiepileptic drugs (NEIAEDs) on statin dose adjustments and low-density lipoprotein (LDL) cholesterol levels in patients with epilepsy...